Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on June 25, 2020. The report details an asset liquidation event conducted by an independent auctioneer, GA Global Partners, involving office equipment, furniture, and surplus assets primarily associated with the Company's discontinued Argus II product line.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or debt metrics. The only specific financial data disclosed relates to the asset auction:
- Anticipated Proceeds: Approximately $350,000 (gross, before sales taxes and expenses).
- Auctioneer Expenses: Up to $30,000.
- Net Proceeds Estimate: Approximately $320,000 (subject to final accounting).
Material Changes
The filing reports a material event regarding the disposal of surplus assets. The auction specifically excluded assets related to the Company's Orion research and development or Orion early feasibility study, indicating a strategic separation between discontinued legacy products and ongoing R&D efforts.
Outlook and Management Commentary
Management notes that GA Global Partners has approximately 44 days to provide the final accounting of proceeds and expenses and to remit the funds. No forward-looking guidance regarding revenue, earnings, or strategic outlook beyond this specific asset sale is provided in this report.
Investor Verification Checklist
- Verify the final net proceeds received from the auction once the 44-day accounting period concludes.
- Confirm the specific allocation of the net proceeds (e.g., debt repayment, operational liquidity, or R&D funding).
- Review subsequent filings for updates on the Orion research and development program, which was explicitly excluded from this asset sale.
- Check for any sales tax liabilities that may reduce the gross proceeds below the $350,000 estimate.